Odyssey Health (ODYY) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Odyssey Health | - | - | - | 61.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 61.37% |
| Oct 31, 2025 | 52.21% |
| Jul 31, 2025 | 36.48% |
| Apr 30, 2025 | 44.54% |
| Jan 31, 2025 | 36.11% |
| Oct 31, 2024 | -8.53% |
| Jul 31, 2024 | 32.36% |
| Apr 30, 2024 | 52.43% |
| Jan 31, 2024 | -44.82% |
| Oct 31, 2023 | 13.60% |
| Jul 31, 2023 | 14.52% |
| Apr 30, 2023 | 4.30% |
| Jan 31, 2023 | -15.73% |
| Oct 31, 2022 | -27.41% |
| Jul 31, 2022 | 79.73% |
| Apr 30, 2022 | -68.60% |
| Jan 31, 2022 | -20.78% |
| Oct 31, 2021 | -29.06% |
| Jul 31, 2021 | -22.99% |
| Apr 30, 2021 | -112.03% |
| Jan 31, 2021 | 43.56% |
| Oct 31, 2020 | 7.45% |
| Jul 31, 2020 | -12.65% |
| Apr 30, 2020 | 11.49% |
| Jan 31, 2020 | 0.81% |
| Oct 31, 2019 | -74.12% |
| Jul 31, 2019 | -514.25% |
| Apr 30, 2019 | -60.87% |
| Jan 31, 2019 | 20.70% |
| Oct 31, 2018 | 66.20% |
| Jul 31, 2018 | 72.00% |
| Apr 30, 2018 | 79.04% |
| Jan 31, 2018 | 28.94% |
| Oct 31, 2017 | 32.96% |